Skip to content
Search

Latest Stories

PDA launches toolkit to help reduce virus risk in pharmacies

The Pharmacists' Defence Association (PDA) has launched a Covid-19 risk management tool to support pharmacy teams against an anticipated second wave of infections as lockdown restrictions have been lessened.

The risk assessment tool will help responsible pharmacists and employers to adopt a systematic approach to both assessing and managing the risks of Covid-19 in the community pharmacy as well as building resilience to prevent closures.


Mark Koziol, PDA Chairman said: “As the government has started to liberalise the lockdown, it is likely that the pharmacies will see even more activity. As healthcare professionals, we know how important it is to maintain infection control measures.

“A second wave of infections is anticipated and for pharmacists, especially those in a community pharmacy setting, this must be a time for extra caution as the risk of infection will likely increase”.

The pharmacists also need to prepare for supporting the test, track and tracing systems now being rolled out across the UK, the association has pointed out.

Following guidance from the GPhC earlier this week, the PDA aims to help pharmacists play their role in reducing the risks of Covid-19 in the pharmacy, and consider mitigating actions to reduce the risk of closure if the whole pharmacy team have to self-isolate, PDA said in a release.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less